
Robin Feldman on Drugs, Money, and Secret Handshakes
EconTalk
00:00
Pricing Power and Pharmaceutical Dynamics
This chapter explores the intricate pricing mechanisms in the pharmaceutical industry, focusing on the influence of Pharmacy Benefit Managers (PBMs) and drug formularies on patient access to medications. It discusses the competitive landscape and anti-competitive practices employed by drug companies, especially in relation to new entrants and the introduction of affordable alternatives. The chapter also critiques the industry's focus on minor drug modifications over genuine innovation, emphasizing the need for transparency and competition to alleviate rising drug costs.
Transcript
Play full episode